Kimberly Page, PhD, MPH

Headshot of Kimberly Page
User Profile Photo

Kimberly Page, PhD, MPH

User Profile Name
Professor, School of Medicine
CTSI Profile Title
User Profile Email


Dr. Page was formerly a Professor in Residence in the Department of Epidemiology and Biostatistics, Division of Infectious Disease, in the Department of Medicine at University of California San Francisco (UCSF). She is now Professor and Chief of Epidemiology, Biostatistics & Preventive Medicine at the University of New Mexico.  She received her Ph.D and MPH from the University of California at Berkeley and completed fellowships at the UCSF Center for AIDS Prevention Studies and the Municipal Health Service in Amsterdam, the Netherlands. She has been the PI of multiple NIH and CDC funded grants, and collaborates with researchers nationally and internationally. Dr. Page is an infectious disease epidemiologist; her research is principally focused on HIV and hepatitis C virus (HCV) infections, principally prevention, natural history, and intervention research in marginalized and underserved populations including injection drug users, and female sex workers. She is currently leading a clinical trial testing a prophylactic HCV vaccine in active injection drug users and a large implementation science trial in Cambodia to reduce drug use and HIV infection in female sex workers. She is the PI of two NIH NIDA funded studies of of HIV and HCV including: the UFO Study, an internationally recognized study of acute HCV in young adult injection drug users, and, the InC3 Collaborative, which brings together investigators and data from preeminent prospective studies of HIV and HCV globally. Dr. Page has been a faculty lead, as Director of Latin and Central America Region for the Fogarty funded International Traineeships in AIDS Prevention Studies (ITAPS) program at UCSF since 2002, providing training and capacity building to scientists from developing countries including Brazil, Argentina, Peru, Guatemala, Mexico, and from Southeast Asia, including Cambodia and Thailand. To learn more about Dr. Page please visit the links below.

User Profile Bio

Displaying 1 - 25 of 224

  1. Murray-Krezan C, Dopp A, Tarhuni L, Carmody MD, Becker K, Anderson J, Komaromy M, Meredith LS, Watkins KE, Wagner K, Page K, CLARO Study Group. Screening for opioid use disorder and co-occurring depression and post-traumatic stress disorder in primary care in New Mexico. Addict Sci Clin Pract. 2023 01 27; 18(1):6.
  2. Carmody MD, Wagner K, Bizstray B, Thornton K, Fiuty P, Rosario AD, Teshale E, Page K. Cascade of Care for Hepatitis C Virus Infection Among Young Adults Who Inject Drugs in a Rural County in New Mexico. Public Health Rep. 2023 Jan 12; 333549221143086.
  3. Killough CM, Madaras A, Phillips C, Hettema J, Ceballos V, Fuentes JE, Rishel Brakey H, Wagner K, Page K. Community health worker insights on promoting research engagement with diverse populations. Front Public Health. 2022; 10:959504.
  4. Goldberg A, Bakhireva LN, Page K, Henrie AM. A Qualitative Scoping Review of Early-Terminated Clinical Trials Sponsored by the Department of Veterans Affairs Cooperative Studies Program From 2010 to 2020. Epidemiol Rev. 2022 12 21; 44(1):110-120.
  5. Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Roche J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Page K, HERO Study Group. Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2022 Dec; 7(12):1112-1127.
  6. Gupta A, Shebl FM, Tong Y, Wagner K, Bassett IV, Page K, Winstanley EL. Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018. Addict Sci Clin Pract. 2022 10 20; 17(1):58.
  7. Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Chan Osilla K, Ryzewicz S, Huerta S, Mazer MW, Leamon I, Messineo G, Watkins KE, Nuckols T, Danovitch I. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2022 07 28; 17(1):39.
  8. Rhed BD, Harding RW, Marks C, Wagner KT, Fiuty P, Page K, Wagner KD. Patterns of and Rationale for the Co-use of Methamphetamine and Opioids: Findings From Qualitative Interviews in New Mexico and Nevada. Front Psychiatry. 2022; 13:824940.
  9. Tully DC, Hahn JA, Bean DJ, Evans JL, Morris MD, Page K, Allen TM. Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships. Clin Infect Dis. 2021 Aug 27.
  10. Karasz A, Singh R, McKee MD, Merchant K, Kim AY, Page K, Pericot-Valverde I, Stein ES, Taylor LE, Wagner K, Litwin AH. Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs. J Subst Abuse Treat. 2022 09; 140:108768.
  11. Mirzazadeh A, Hosseini-Hooshyar S, Shahesmaeili A, Sharafi H, Shafiei M, Zarei J, Mousavian G, Tavakoli F, Ghalekhani N, Shokoohi M, Khezri M, Mehmandoost S, Shojaei MR, Karamouzian M, Briceno A, Morris MD, Alavian SM, Haghdoost AA, Sharifi H, Page KA. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study. Int J Drug Policy. 2022 04; 102:103580.
  12. Harding RW, Wagner KT, Fiuty P, Smith KP, Page K, Wagner KD. "It's called overamping": experiences of overdose among people who use methamphetamine. Harm Reduct J. 2022 01 16; 19(1):4.
  13. Page K, Murray-Krezan C, Leeman L, Carmody M, Stephen JM, Bakhireva LN. Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy. Addict Sci Clin Pract. 2022 01 06; 17(1):3.
  14. Killough C, Ortegon ER, Vasireddy R, Kincaid T, Silverblatt H, Crisanti A, Page K. Training Psychiatrists in New Mexico: Reflections from Psychiatry Residents Who Participated in a Rural Track Versus a Traditional Program Alone over the Past Decade. Acad Psychiatry. 2022 Aug; 46(4):470-474.
  15. Kandathil AJ, Cox AL, Page K, Mohr D, Razaghi R, Ghanem KG, Tuddenham SA, Hsieh YH, Evans JL, Coller KE, Timp W, Celentano DD, Ray SC, Thomas DL. Plasma virome and the risk of blood-borne infection in persons with substance use disorder. Nat Commun. 2021 11 25; 12(1):6909.
  16. Ass'ad NA, Shore X, Myers O, Camacho AR, Jacquez Q, Pollard C, Cook LS, Leng S, Page K, Sood A, Zychowski KE. VCAM-1 Is Upregulated in Uranium Miners Compared to Other Miners. Life (Basel). 2021 Nov 11; 11(11).
  17. Facente SN, Patel S, Hecht J, Wilson E, McFarland W, Page K, Vickerman P, Fraser H, Burk K, Morris MD. Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs. Clin Infect Dis. 2021 Sep 15; 73(6):e1290-e1295.
  18. Brites C, Borges ÁH, Sprinz E, Page K. Editorial: HIV and Viral Co-infections. Front Microbiol. 2021; 12:731337.
  19. Del Rosario A, Eldredge JD, Doorley S, Mishra SI, Kesler D, Page K. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review. J Viral Hepat. 2021 Jul 27.
  20. Hahn JA, Murnane PM, Vittinghoff E, Muyindike WR, Emenyonu NI, Fatch R, Chamie G, Haberer JE, Francis JM, Kapiga S, Jacobson K, Myers B, Couture MC, DiClemente RJ, Brown JL, So-Armah K, Sulkowski M, Marcus GM, Woolf-King S, Cook RL, Richards VL, Molina P, Ferguson T, Welsh D, Piano MR, Phillips SA, Stewart S, Afshar M, Page K, McGinnis K, Fiellin DA, Justice AC, Bryant K, Saitz R. Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis. Alcohol Clin Exp Res. 2021 06; 45(6):1166-1187.
  21. Meredith LS, Komaromy MS, Cefalu M, Murray-Krezan C, Page K, Osilla KC, Dopp AR, Leamon I, Tarhuni L, Hindmarch G, Jacobsohn V, Watkins KE, CLARO Study Group. Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder. Contemp Clin Trials. 2021 05; 104:106354.
  22. Page K, Melia MT, Veenhuis RT, Winter M, Rousseau KE, Massaccesi G, Osburn WO, Forman M, Thomas E, Thornton K, Wagner K, Vassilev V, Lin L, Lum PJ, Giudice LC, Stein E, Asher A, Chang S, Gorman R, Ghany MG, Liang TJ, Wierzbicki MR, Scarselli E, Nicosia A, Folgori A, Capone S, Cox AL. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med. 2021 02 11; 384(6):541-549.
  23. Wagner K, Zhong Y, Teshale E, White K, Winstanley EL, Hettema J, Thornton K, Bisztray B, Fiuty P, Page K. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Drug Alcohol Depend. 2021 03 01; 220:108527.
  24. Evans JL, Couture MC, Carrico A, Stein ES, Muth S, Phou M, Aynar L, Song N, Chhit S, Neak Y, Maher L, Page K. Joint effects of alcohol and stimulant use disorders on self-reported sexually transmitted infections in a prospective study of Cambodian female entertainment and sex workers. Int J STD AIDS. 2021 03; 32(4):304-313.
  25. Morris MD, Yen IH, Shiboski S, Evans JL, Page K. Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection Risk. J Urban Health. 2020 12; 97(6):831-844.